Epithelioid inflammatory myofibroblastic sarcoma with exceptionally long response to lorlatinib—a case reportRafał Becht, Paweł Domagała, Katarzyna Kozak et al.|Therapeutic Advances in Medical Oncology|2024Cited by 2